NAT2 polymorphism in Omani gastric cancer patients-risk predisposition and clinicopathological associations

被引:12
作者
Al-Moundhri, Mansour S.
Al-Kindi, Mohamed
Al-Nabhani, Maryam
Al-Bahrani, Bassim
Burney, Ikram A.
Al-Madhani, Ali
Ganguly, Shyam S.
Tanira, Misbah
机构
[1] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Med, Med Oncol Unit, Muscat, Oman
[2] Sultan Qaboos Univ, Dept Biochem & Genet, Muscat, Oman
[3] Royal Hosp, Natl Canc Inst, Muscat, Oman
[4] Sohar Hosp, Dept Med, Sohar, Oman
[5] Sultan Qaboos Univ, Dept Epidemiol & Med Stat, Muscat, Oman
[6] Sultan Qaboos Univ, Dept Pharmacol, Muscat, Oman
关键词
gastric cancer; polymorphism; NAT2; H pylori; Arab; Omani;
D O I
10.3748/wjg.v13.i19.2697
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To study whether N-acetyltransferase 2 (NAT2) genotypes and phenotypes are associated with increased risk factor for gastric cancer in Omani patients and to study the clinico-pathological correlations and the prognostic significance of NAT2. METHODS: Genomic DNA was extracted from peripheral blood of 100 gastric cancer patients and 100 control subjects. NAT2 genotyping was performed using DNA sequencing. The prognostic significance of NAT2 and other clinicopathological features was assessed by univariate and multivariate analyses. RESULTS: We observed no significant association between NAT2 genotypes and phenotypes and gastric cancer risk. The NAT2 phenotype polymorphisms and gastric cancer risk predisposition were not modified by concomitant H pylori infection and smoking. There was no significant association between NAT2 and clinicopathological features, and NAT2 had no independent prognostic significance. CONCLUSION: In the current study, NAT2 genotypes and phenotypes are not associated with gastric cancer risk predisposition. Moreover NAT2 phenotypes had no clinicopathological associations or prognostic significance. (C) 2007 The WJG Press. All rights reserved.
引用
收藏
页码:2697 / 2702
页数:6
相关论文
共 29 条
[1]  
Boissy RJ, 2000, INT J CANCER, V87, P507, DOI 10.1002/1097-0215(20000815)87:4<507::AID-IJC7>3.3.CO
[2]  
2-9
[3]   New strategies for the prevention of gastric cancer:: Helicobacter pylori and genetic susceptibility [J].
Correa, P .
JOURNAL OF SURGICAL ONCOLOGY, 2005, 90 (03) :134-138
[4]   Interleukin-1 polymorphisms associated with increased risk of gastric cancer [J].
El-Omar, EM ;
Carrington, M ;
Chow, WH ;
McColl, KEL ;
Bream, JH ;
Young, HA ;
Herrera, J ;
Lissowska, J ;
Yuan, CC ;
Rothman, N ;
Lanyon, G ;
Martin, M ;
Fraumeni, JF ;
Rabkin, CS .
NATURE, 2000, 404 (6776) :398-402
[5]  
Gonzalez C A, 2002, IARC Sci Publ, V156, P79
[6]   Genetic susceptibility and gastric cancer risk [J].
González, CA ;
Sala, N ;
Capellá, G .
INTERNATIONAL JOURNAL OF CANCER, 2002, 100 (03) :249-260
[7]  
HALDANE JBS, 1956, ANN HUM GENET, V20, P309
[8]  
Hein DW, 2000, CANCER EPIDEM BIOMAR, V9, P29
[9]  
Hung C F, 1999, Zhonghua Yi Xue Za Zhi (Taipei), V62, P203
[10]  
Katoh T, 2000, INT J CANCER, V85, P46, DOI 10.1002/(SICI)1097-0215(20000101)85:1<46::AID-IJC8>3.0.CO